IRIS
GHIA, PAOLO PROSPERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.530
NA - Nord America 1.139
AS - Asia 116
OC - Oceania 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.796
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.133
SE - Svezia 1.006
IT - Italia 263
FI - Finlandia 69
IE - Irlanda 63
DE - Germania 44
CN - Cina 42
NL - Olanda 26
IN - India 24
AE - Emirati Arabi Uniti 20
CH - Svizzera 9
FR - Francia 9
GB - Regno Unito 7
BE - Belgio 6
CA - Canada 6
IR - Iran 6
AU - Australia 5
RU - Federazione Russa 5
SG - Singapore 5
ES - Italia 4
PH - Filippine 4
PL - Polonia 4
TW - Taiwan 4
UA - Ucraina 4
HK - Hong Kong 3
NO - Norvegia 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
EU - Europa 2
IQ - Iraq 2
KZ - Kazakistan 2
MK - Macedonia 2
AR - Argentina 1
FJ - Figi 1
IL - Israele 1
JP - Giappone 1
MY - Malesia 1
OM - Oman 1
RO - Romania 1
SI - Slovenia 1
Totale 2.796
Salva come PNG Salva come JPEG
Città #
Lawrence 328
Princeton 328
Ashburn 186
Milan 155
Helsinki 69
New York 69
Dublin 63
Shanghai 36
Rome 21
Dubai 20
Seattle 18
Pune 16
Ridgewood 14
Los Angeles 12
Dronten 10
Zurich 9
Washington 8
Meppel 6
Mol 6
Nuneaton 6
Borås 5
Cesano Boscone 5
Mountain View 4
Redwood City 4
Warsaw 4
Boardman 3
Dasmariñas 3
Signa 3
Sydney 3
Andria 2
Astana 2
Baghdad 2
Banqiao 2
Barcelona 2
Bergen 2
Berlin 2
Cairo 2
Catania 2
Creon 2
Duncan 2
Frankfurt am Main 2
Freiburg im Breisgau 2
Guangzhou 2
Hangzhou 2
Hanover 2
Hong Kong 2
Las Vegas 2
Madrid 2
Melbourne 2
Mumbai 2
Nagpur 2
Padova 2
Paris 2
Perugia 2
Pistoia 2
Prague 2
Reggio Calabria 2
Romainville 2
Sacramento 2
Skopje 2
Soveria Mannelli 2
Taipei 2
Tampa 2
Toronto 2
Torre Del Greco 2
Turin 2
Vellore 2
Zanjan 2
Alessandria 1
Amsterdam 1
Andover 1
Anzio 1
Astoria 1
Baguio City 1
Bergamo 1
Bordeaux 1
Boydton 1
Buenos Aires 1
Carate Brianza 1
Copenhagen 1
Easley 1
Esslingen am Neckar 1
Falkenstein 1
Florence 1
Fremont 1
Garland 1
Genoa 1
Gioia Tauro 1
Groningen 1
Henderson 1
Ismaning 1
Kuala Lumpur 1
Lewisham 1
Ljubljana 1
Lomazzo 1
Lonate Pozzolo 1
Muscat 1
Naaldwijk 1
Nantes 1
Naples 1
Totale 1.524
Salva come PNG Salva come JPEG
Nome #
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial 26
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 24
Rugarli. Medicina interna sistematica 23
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia 22
Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens 18
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression 18
3D co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents 18
3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells 18
Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia 18
Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Results from the MRD Cohort of the Phase 2 CAPTIVATE Study 17
Prognostic relevance of MYD88 mutations in CLL: the jury is still out 16
Chronic lymphocytic leukemia 15
Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia 15
A novel Rag2(-/-)gamma(-/-)(c)-xenograft model of human CLL 15
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases 15
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 15
HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment 15
A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia 15
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 15
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 15
T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities 15
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia 14
A novel molecular complex expressed on immature B cells: A possible role in T cell-independent B cell development 14
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications 14
A screening study of Chlamydia psittaci infection in 172 cases of nodal and extranodal non-hodgkin lymphomas 14
Monoclonal B-cell lymphocytosis: right track or red herring? 14
Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia 14
A look into the future: can minimal residual disease guide therapy and predict prognosis in chronic lymphocytic leukemia? 14
A woman and her canary: a tale of chlamydiae and lymphomas 14
Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia 14
A complementary role of multiparameter flow-cytometry and high-throughput sequencing for minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL): An european research initiative on CLL (ERIC) study 14
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabine 14
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results 14
Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia 14
Assessing Patients' Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece 14
CD4+T cells sustain aggressive chronic lymphocytic leukemia in Em- TCL1 mice through a CD40L-independent mechanism 14
A single-tube multiplex method for monitoring mutations in cysteine 481 of Bruton Tyrosine Kinase (BTK) gene in chronic lymphocytic leukemia patients treated with ibrutinib 14
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial 13
Monoclonal CD5(+) and CD5(-) B-lymphocyte expansions are frequent in the peripheral blood of the elderly 13
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 13
ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage 13
KAP1 regulates gene networks controlling mouse B-lymphoid cell differentiation and function 13
Bone Marrow Histopathology in the Diagnostic Evaluation of Splenic Marginal-zone and Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Reliable Substitute for Spleen Histopathology? 13
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study 13
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor 13
Targeting B-cell anergy in chronic lymphocytic leukemia. 13
Distinct Innate Immunity Pathways to Activation and Tolerance in Subgroups of Chronic Lymphocytic Leukemia with Distinct Immunoglobulin Receptors. 13
V delta 1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid 13
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation 13
Clonal B-cell lymphocytosis: a new member? 13
A new life for rituximab? 13
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study 13
Is good clinical practice becoming poor clinical care? 12
Another piece of the puzzle: is there a "nodal" monoclonal B-cell lymphocytosis? 12
A frequent EcoRI polymorphism in the bcl-2 gene 12
Cytokines involved in the progression of multiple myeloma 12
In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor 12
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia 12
In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors 12
B cell anergy modulated by TLR1/2 and the MIR-17∼92 cluster underlies the indolent clinical course of chronic lymphocytic leukemia stereotyped subset #4 12
The phase 3 DUO trial: Duvelisib vs ofatumumab in relapsed and refractory CLL/SLL 12
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia 12
Zanubrutinib monotherapy for patients with treatment naïve chronic lymphocytic leukemia and 17p deletion 12
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 12
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection 11
In vitro growth of human multiple myeloma: implications for biology and therapy 11
CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells 11
Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models 11
MBL Versus CLL How Important Is the Distinction? 11
Targeting Hedgehog in haematological malignancies 11
Antigen selection in B-cell lymphomas-Tracing the evidence 11
Reprogramming cell death: BCL2 family inhibition in hematological malignancies 11
General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. 11
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials 11
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project 11
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes 11
Reply to "CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report" Analysis of six hematological centers in Lombardy : On behalf of CLL commission of Lombardy Hematology Network (REL) 11
Infrequent "chronic lymphocytic leukemia-specific" immunoglobulin stereotypes in aged individuals with or without low count monoclonal B cell lymphocytosis 11
ABVD CAN BE SAFELY ADMINISTERED REGARDLESS OF ABSOLUTE NEUTROPHIL COUNT AND WITHOUT G-CSF SUPPORT IN HODGKIN'S LYMPHOMA PATIENTS 11
Relevance of Minimal Residual Disease in the Era of Targeted Agents 11
Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis 11
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset 8 11
Toll-Like receptor stimulation in splenic marginal zone lymphoma can modulate cell signaling, activation and proliferation 11
Acalabrutinib monotherapy for treatment of chronic lymphocytic leukaemia (ACE-CL-001): analysis of the Richter transformation cohort of an open-label, single-arm, phase 1–2 study 11
MINIMAL RESIDUAL DISEASE-DRIVEN TREATMENT INTENSIFICATION WITH SEQUENTIAL ADDITION OF IBRUTINIB TO VENETOCLAX IN R/R CLL 10
Monoclonal B lymphocytosis in the general population 10
B-cell development: a comparison between mouse and man 10
Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients 10
Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding 10
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis 10
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2 10
KIBRA gene methylation is associated with unfavorable biological prognostic parameters in chronic lymphocytic leukemia 10
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL 10
Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions. 10
Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci 10
Chronic lymphocytic leukaemia 10
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia 10
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia 10
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia 10
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia 10
Totale 1.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.224
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0 0 0 0 0 0 0 0 0 23 0 0
2019/202011 11 0 0 0 0 0 0 0 0 0 0 0
2020/202151 0 0 0 0 22 25 3 0 1 0 0 0
2021/2022193 0 0 0 79 28 6 17 17 16 9 6 15
2022/20231.988 758 410 124 3 39 254 71 111 85 32 34 67
2023/2024636 42 58 49 182 68 127 22 59 4 25 0 0
Totale 3.075